N/A
N=234
Empowering Patients On Choices for Renal Replacement Therapy (Aim 3) (EPOCH-RRT)
Chronic Kidney Disease
Bottom Line
View on ClinicalTrials.gov: NCT02488317 ↗Enrolled (actual)
234
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Preference for Shared Decision Making — 22; 19; 35; 44 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Decision Aid (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Arbor Research Collaborative for Health
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Preference for Shared Decision Making |
22; 19; 35; 44; 38; 35 | — |
| PRIMARY Decisional Conflict |
43.6; 42.5; 29.1; 42.5 | — |
| PRIMARY Decision Self-efficacy |
82.8; 79.9; 82.0; 79.9 | — |
| PRIMARY Knowledge |
90.3; 76.5 | — |
| PRIMARY Preparation for Decision Making |
76.39 | — |
Summary
Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT) study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis.
For Aim 3, the investigators are going to compare measures related to the decision-making process between patients receiving and not receiving a decision aid focusing on Peritoneal Dialysis and Hemodialysis.
Eligibility Criteria
Inclusion Criteria
- 18 years and older
- Speaks English
- Has access to the internet
Exclusion Criteria
Data sourced from ClinicalTrials.gov (NCT02488317). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.